141 related articles for article (PubMed ID: 2534648)
21. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.
Querfeld C; Rosen ST; Kuzel TM; Kirby KA; Roenigk HH; Prinz BM; Guitart J
Arch Dermatol; 2005 Mar; 141(3):305-11. PubMed ID: 15781671
[TBL] [Abstract][Full Text] [Related]
22. [The application of photopheresis in the therapy of cancerous and autoimmune diseases].
Dall'Amico R; Zacchello G; Heald P
Recenti Prog Med; 1991 May; 82(5):294-9. PubMed ID: 1887157
[TBL] [Abstract][Full Text] [Related]
23. Treatment of cutaneous T-cell lymphoma.
Zackheim HS
Semin Dermatol; 1994 Sep; 13(3):207-15. PubMed ID: 7986690
[TBL] [Abstract][Full Text] [Related]
24. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
25. Sustained remission of Sézary syndrome.
Bouwhuis SA; McEvoy MT; Davis MD
Eur J Dermatol; 2002; 12(3):287-90. PubMed ID: 11978575
[TBL] [Abstract][Full Text] [Related]
26. Photopheresis: a new therapeutic concept.
Edelson RL
Yale J Biol Med; 1989; 62(6):565-77. PubMed ID: 2700056
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
28. Etretinate as an effective adjunctive therapy for recalcitrant palmar/plantar hyperkeratosis in patients with erythrodermic cutaneous T cell lymphoma undergoing photopheresis.
Lim HW; Harris HR
Dermatol Surg; 1995 Jul; 21(7):597-9. PubMed ID: 7606369
[TBL] [Abstract][Full Text] [Related]
29. Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis.
Lee CH; Mamelak AJ; Vonderheid EC
Int J Dermatol; 2007 Nov; 46(11):1198-204. PubMed ID: 17988344
[TBL] [Abstract][Full Text] [Related]
30. Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma.
Miller JD; Kirkland EB; Domingo DS; Scull H; Jekutis B; Dallas M; Cooper KD; Baron ED
Photodermatol Photoimmunol Photomed; 2007 Oct; 23(5):163-71. PubMed ID: 17803594
[TBL] [Abstract][Full Text] [Related]
31. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
[TBL] [Abstract][Full Text] [Related]
32. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
[TBL] [Abstract][Full Text] [Related]
33. Extracorporeal photochemotherapy for cutaneous T-cell lymphoma.
Med Lett Drugs Ther; 1988 Oct; 30(776):96. PubMed ID: 3050409
[No Abstract] [Full Text] [Related]
34. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
[TBL] [Abstract][Full Text] [Related]
35. Photopheresis therapy for cutaneous T-cell lymphoma.
Duvic M; Hester JP; Lemak NA
J Am Acad Dermatol; 1996 Oct; 35(4):573-9. PubMed ID: 8859287
[TBL] [Abstract][Full Text] [Related]
36. Metastasizing squamous cell carcinomas in a patient treated with extracorporeal photopheresis for cutaneous T-cell lymphoma.
Hoetzenecker W; Benedix F; Woelbing F; Yazdi A; Breuninger H; Röcken M; Berneburg M
Acta Derm Venereol; 2007; 87(5):445-6. PubMed ID: 17721661
[No Abstract] [Full Text] [Related]
37. Measuring HRQOL in patients with cutaneous T-cell lymphoma undergoing therapy with oral bexarotene and extracorporeal photopheresis.
Demierre MF; Ferzli P; Miller D
Arch Dermatol; 2007 May; 143(5):659-61. PubMed ID: 17515522
[No Abstract] [Full Text] [Related]
38. Treatment of cutaneous T-cell lymphoma: an update.
Young JW
J Am Osteopath Assoc; 1993 May; 93(5):591-8, 603. PubMed ID: 8314721
[TBL] [Abstract][Full Text] [Related]
39. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
[TBL] [Abstract][Full Text] [Related]
40. Staging and management of cutaneous T-cell lymphoma.
Scarisbrick JJ
Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]